[10]. If LRRK2-carrier women have a greater load than men, women might be expected to develop disease earlier or progress faster than men, or both. A recent study on a large LRRK2 PD cohort confirmed the former hypothesis, demonstrating that onset of disease occurs 5 years earlier in women [11]. This evidence concerns the gene LRRK2 and Parkinson disease.